Abstract
To examine the relationship between attention and anxiety and the response to methylphenidate in children with attention deficit hyperactivity disorder (ADHD), a total of 57 boys, between the ages of 7–12 years, were assessed for their attention and level of anxiety. Methylphenidate was administered for a week in a randomized double-blind drug/placebo–drug cross-over design. The levels of anxiety were evenly distributed between the inattentive and hyperactive/impulsive types. Anxiety was significantly correlated with the attention as reported by both teachers and parents. The response to methylphenidate was inversely correlated with the reported anxiety level only in boys with the hyperactive/impulsive and combined types. The higher the level of anxiety, the lower level of response to methylphenidate was observed. In the assessment and treatment of children with ADHD, the level of anxiety should be evaluated and taken into account while planning and monitoring treatment regiment.
Similar content being viewed by others
References
AACAP Official Action (2007) Practice parameter for the assessment and treatment of children and adolescents with attention deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 46(7):894–921
Abikoff H, McGough J, Vitiello B et al (2005) Sequential pharmacotherapy for children with comorbid attention deficit/hyperactivity and anxiety disorders. J Am Acad Child Adolesc Psychiatry 44(5):418–427
Adler AL, Barley RA, Newcorn JH et al (2007) Managing ADHD in children, adolescents, and adults with comorbid anxiety in primary care. J Clin Psychiatry 9(2):129–138
American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders, 4th edn (DSM-IV)). American Psychiatric Association, Washington
Angold S, Costello EJ, Erkanli A (1999) Comorbidity. J Child Psychol Psychiatry 40(1):57–87
Bedard AC, Tannock R (2008) Anxiety, methylphenidate response and working memory in children with ADHD. J Atten Disord 11(5):546–547
Biederman J, Newcorn J, Sprich S (1991) Comorbidity of a attention deficit by hyperactivity disorder with conduct, depressive, anxiety and other disorders. Am J Psychiatry 148(5):564–577
Biederman J, Hirshleft Becker DR, Rosenbaum JF et al (2001) Further evidence of association between behavioral inhibition and social anxiety in children. Am J Psychiatry 158(10):1673–1679
Brown RT, Amler RW, Freeman WS et al (2005) American Academy of Pediatrics the Committee on Quality Improvement. American Academy of Subcommittee on Attention-Deficit/Hyperactivity disorder. Pediatrics 115(6):e749–e757
Carter S, Syed-Sabir H (2008) How to use a rating score to diagnose attention deficit hyperactivity disorder. Arch Dis Child Educ Pract Ed 93(5):159–162
Daleiden EL, Vasey MV (1997) An informative-processing perspective on childhood anxiety. Clin Psychol Rev 17(4):407–429
Diamond IR, Tannock R, Schachar RJ (1999) Response to methylphenidate in children with ADHD and comorbid anxiety. J Am Acad Child Adolesc Psychiatry 38(4):402–409
DuPaul G, Barkley RA, McMurray MB (1994) Response of children with ADHD to methylphenidate: interaction with internalizing symptoms. J Am Acad Child Adolesc Psychiatry 33(60):894–903
Efron D, Jarman F, Barker M (1997) Methylphenidate versus dexamphetamine in children with attention deficit hyperactivity disorder: a double-blind, crossover trial. Pediatrics 100(6):e6
Eiraldi RB, Power TJ, Nezu CM (1997) Patterns of comorbidity associated with subtypes of attention-deficit/hyperactivity disorder among 6- to 12-year-old children. J Am Acad Child Adolesc Psychiatry 36(4):503–514
Etkin A, Klemenhagen KC, Dudman JT, Rogan MT, Hen R, Kandel ER, Hirsch J (2004) Individual differences in trait anxiety predict the response of the basolateral amygdala to unconsciously processed fearful faces. Neuron 44(6):1043–1055
Ghanizadeh A (2008) Psychiatric comorbidity differences in clinic—referred children and adolescents with ADHD according to the subtypes and gender. J Neurol 24(6):679–684
Goez H, Back-Bennet O, Zelnic N (2007) Differential stimulant response on attention in children with comorbid anxiety and oppositional defiant disorders. J Child Neurol 22(5):538–542
Goyette CH, Conners CK, Ulrich RF (1978) Normative data on revised Conners Parent Teachers Rating Scales. J Abnorm Child Psychol 6(2):221–226
Gray JA (1987) The psychology of fear and stress. Cambridge University Press, New York
Hechtman L, Abikoff H, Klein RG et al (2004) Academic achievement and emotional status of children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment. J Am Acad Child Adolesc Psychiatry 43(7):812–819
Kagan J (1965) The matching familiar figures test. Harvard University Press, Cambridge
Kellogg J, Hopko DR, Ashcraft MH (1999) The effect of time pressure on arithmetic performance. J Anxiety Disord 13(6):591–600
Lahey BB, Pelham WE, Schaughency EA et al (1988) Dimensions and types of attention deficit disorder. J Am Acad Child Adolesc Psychiatry 27(3):330–335
Levine MD (1992) The ANSER system. Pediatrics 89(1):170–171
Livingstone RL, Dykman J, Ackerman PT (1992) Psychiatric comorbidity and response to two doses of methylphenidate in children with attention deficit disorder. J Child Adolesc Psychol 2(2):115–122
March JS, Swanson JM, Arnold LE, Hoza B et al (2000) Anxiety as a predictor and outcome variable in the multimodal treatment study of children with ADHD (MTA). J Abnorm Child Psychol 28(6):527–541
Milberger S, Biederman J, Faraone SV et al (1995) Attention deficit hyperactivity disorder and comorbid disorders: issues of overlapping symptoms. Am J Psychiatry 152(12):1793–1799
Or D, Cohen A, Tirosh E (2010) The reliability and validity of the aggregate neurobehavioral student health and educational review parent’s questionnaire (ANSER-PQ). J Child Neurol 25(2):157–164
Pliszka S (1989) Effect of anxiety on cognition, behavior and stimulant response in ADHD. J Am Acad Child Psychiatry 28(6):882–887
Pliszka SR (1992) Comorbidity of attention-deficit hyperactivity disorder and overanxious disorder. J Am Acad Child Psychiatry 31(2):197–203
Pliszka S (1998) Comorbidity of attention-deficit hyperactivity disorder with psychiatric disorder. An overview. J Clin Psychiatry 59(7):50–58
Power TJ, Costigan TE, Eiraldi RB et al (2004) Variations in anxiety and depression as a function of ADHD subtypes defined by DSM-IV: do subtype differences exist or not. J Abnorm Child Psychol 32(1):27–37
Schmidt SL, Snyder TJ, Rouget AC et al (2000) Empirical analysis of the selective attention and associated behavior checklists of the aggregate neurobehavioral student health and educational review. J Dev Behav Pediatr 21(3):165–171
Spencer TJ (2006) ADHD and comorbidity in childhood. J Clin Psychiatry 67(8):27–31
Spencer T, Biederman J, Wilens T (1999) Attention-deficit/hyperactivity disorder and comorbidity. Pediatr Clin N Am 46(5):915–927
Tannock R, Ichowicz A, Schachar R (1995) Differential effects of methylphenidate on working memory in ADHD children with and without comorbid anxiety. J Am Acad Child Adolesc Psychiatry 34(7):886–896
Tirosh E, Elhasid R, Cohen-Bar Kamah S et al (1993) Predictive value of placebo methylphenidate. Pediatr Neurol 9(2):131–133
Vila G, Nollet-Clemencon C, de Blic J et al (1999) Assessment of anxiety disorders in asthmatic children. Psychosomatics 40(5):404–413
Volk HE, Neuman RJ, Todd RD (2005) A systematic evaluation of ADHD and comorbid psychopathology in a population-based twin sample. J Am Acad Child Adolesc Psychiatry 44(8):768–775
Acknowledgments
We are indebted to the children and parents who participated and to R. Abiry for her help in the preparation of this manuscript.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Moshe, K., Karni, A. & Tirosh, E. Anxiety and methylphenidate in attention deficit hyperactivity disorder: a double-blind placebo-drug trial. ADHD Atten Def Hyp Disord 4, 153–158 (2012). https://doi.org/10.1007/s12402-012-0078-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12402-012-0078-2